Key advance toward treatment for most common adult form of muscular dystrophy
Thursday, November 20, 2008 - 11:56
in Health & Medicine
Scientists in New York are reporting a critical first step toward development of a long-sought drug to treat myotonic muscular dystrophy (MMD), the most common form of muscular dystrophy in adults. MMD affects about 1 in 8,000 people. Their findings are scheduled for publication the recent issue of ACS' weekly Journal of the American Chemical Society...
Read the whole article on Science Centric
More from Science Centric
Related
- New therapy substitutes missing protein in those with muscular dystrophyTue, 26 May 2009, 15:29:24 EDT
- Small molecule inhibits pathology associated with myotonic dystrophy type 1Mon, 7 Sep 2009, 17:32:08 EDT
- Researchers discover molecular basis of a form of muscular dystrophyWed, 30 Apr 2008, 14:57:43 EDT
- Researchers identify gene associated with muscular dystrophy-related vision problemsTue, 21 Apr 2009, 0:28:56 EDT
- Risk factors for sudden death for adult muscular dystrophy identifiedThu, 19 Jun 2008, 3:42:27 EDT